Han Yu Pharmaceutical: plans to raise funds through a private placement of no more than 968 million yuan for the research and development of Simeglutide and other projects.

Hanyu Pharmaceutical announced that it plans to issue shares to specific investors, raising a total fund of up to 968 million yuan, for the construction of a polypeptide drug production line and green intelligent expansion project, polypeptide fragment production expansion project, research laboratory upgrade project, somatostatin peptide research and development project, and supplementary working capital.